SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " earnings " 829 found 🔀 AI-powered Shuffle
Q3: Omnicom’s Media Business Is Growing, But Is It Agent-Proof?
If AI agents can plan and buy media, who needs a holding company? Good question. It came up during Omnicom's Q3 earnings on Thursday.
AMC Entertainment Holdings, Inc. to Announce Third Quarter 2026 Results and Host Earnings Webcast
LEAWOOD, Kan., October 22, 2026--AMC Entertainment Holdings, Inc. (NYSE: AMC) ("AMC" or "the Company"), the largest theatrical exhibition company in the world, announced today that it will report its results for the third quarter ended September 30, 2026, on Wednesday, November 4, 2026.
The One Chart That Explains Why Netflix Cleaned House
(Welcome to my weekly streaming ratings report, the single best guide to what’s popular in streaming TV and what isn’t. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. If you were forwarded this email, please subscribe to get these insights each week.) Yeah, I’ll be honest: I went with a clickbait-y headline today. One chart? That explains everything? That’s as clickbait-y as it gets. But let’s be real. I’m analyzing a dataset that I’ve built over six years, and c’mon, I never write articles which feature just one chart! If you think this article—which includes a level of data detail unheard of in journalism twenty years ago—is clickbait, fine by me. Really, what I’m doing is using data to explain Netflix’s recent strategy changes, since the story of the month is the turbulence at Netflix. First, head of content Bela Bajaria was fired. Then head of film Dan Lin followed her to the unemployment ranks. (Along with, sadly, 1,000 other Netflix workers.) And then Netflix delivered a “sub-optimal” earnings report, which continued their year-long stock price slide. Then came a flood of articles explaining why all this is happening. (Mine’s coming shortly, rest assured.) I realized I had the perfect chart to explain Netflix’s woes. Specifically, Nielsen’s weekly top ten charts. Usually I focus on one or two weeks in my Streaming Ratings Reports, but sometimes it’s worth stepping back to look at the larger story. And hoo boy, what a story. This article is my annual (plus three months) follow-up to one of my most popular articles of last year. (And a topic I’ve been visualizing for the last half decade.) Subscribe Netflix’s Share of The Nielsen Charts Continues to Decline
Pullup Entertainment Q2 2027 Earnings Call Is Live
Pullup Entertainment's quarterly earnings call has just begun.Live earnings calls are not yet supported in the mobile app. To listen and follow along in real time, open TradingView website in your browser.
Selective partnerships define Scottie Scheffler’s off-course business strategy
Scottie Scheffler’s endorsement strategy prioritizes select, values-aligned partners over volume, resulting in $30M annually off the course versus $50M in PGA Tour earnings, a rare split among elite athletes.
Nasdaq Revenue Rises 14% as Financial Technology Business Expands
Nasdaq reported higher third-quarter revenue and earnings Thursday (Oct. 22), supported by growth in its financial technology and capital markets
What International Business Machines (IBM) Said on Its Q3 Earnings Call
International Business Machines (NYSE:IBM) reported third-quarter 2026 revenue growth of 6% at constant currency, led by accelerating software sales, infrastructure demand and modest consulting growth. The company said operating pre-tax margin expanded 70 basis points and diluted operating earnings
Federal report shows wage growth well below rate of inflation
New federal data shows that median weekly earnings among full-time workers in the third quarter of 2026 rose 1.5% compared with the same period in 2025. The gain was below...
Meta earnings: Mark Zuckerberg says Muse AI app hits over 10M users
CEO Mark Zuckerberg announces 10M users for Meta's Muse AI app since September. Meta's stock was up after its third-quarter earnings report.
Bank of America (BAC): Is Its Wealth Business More Valuable Than the Headline Bank Suggests?
Bank of America Corporation (NYSE:BAC) has a wealth franchise that deserves attention beyond lending spreads. Second-quarter 2026 Global Wealth and Investment Management net income reached $1.41 billion, roughly 16% of group earnings. That contribution matters when comparing bank stocks favored by billionaires: advisory fees diversify revenue, although rising markets still influence their value. Bank of […]
Baidu (BIDU) Expands Its AI Business, but the Core Revenue Recovery Remains Uncertain
Baidu, Inc. (NASDAQ:BIDU) is expanding autonomous driving and AI services while its traditional business stays under pressure. That raises a hard valuation question: can the new activities grow fast enough, and profitably enough, to replace what the established business is losing? At roughly 19 times forward earnings, investors pay for that transition to work. They […]
Elevance Health Shares Rise as Third-Quarter Earnings Beat Estimates and 2026 Guidance Increases
Elevance Health Inc. (NYSE:ELV) shares advanced 1.
Philip Morris Says Global Wars Have Disrupted Its Business and Clouded Earnings Outlook
Tobacco giant Philip Morris says it anticipates the global conflicts will impact operating income this year.
Elevance Health: Q3 Earnings Snapshot
INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Elevance Health Inc. (ELV) on Wednesday reported third-quarter earnings of $1.
How Investors May Respond To PENN Entertainment (PENN) Massachusetts Slot Debate
PENN Entertainment has opposed proposed legislation in Massachusetts that would permit historical horse racing devices that function like slot machines. The company argues these terminals could shift up to US$216 million in annual gaming revenue and affect an estimated 1,074 casino jobs across the state. The company has recently reported earnings that exceeded consensus estimates, with an average surprise of 72.86% over the last two quarters. This highlights an operating profile where...
How Small Pharmacy Expansion Will Impact CVS Health (CVS) Investors
CVS Health has been rolling out smaller pharmacy focused stores, expanding MinuteClinic sites and raising its 2026 revenue and earnings outlook, alongside new efforts in benefit transparency and women’s midlife health research. The push into underserved neighborhoods with compact pharmacies and clinics points to a tighter focus on access, operating efficiency and aligning physical sites with where prescription demand actually shows up. This article examines how CVS Health’s investment...
SpaceX’s Musk Lauds Its Soaring Cloud Business and Possible Tesla Merger
SpaceX put on a bit of a show for shareholders today—and I’m not referring to the sizzle reel of rocket and space videos it showed on its earnings call. No, the big attention grabber was the update from CEO Elon Musk on the progress of SpaceX’s contemplated merger with Tesla and just how ...
SpaceX touts possible Tesla merger after profits soar
After a stellar SpaceX earnings announcement, chief executive Elon Musk said the rocket company is considering a merger with Tesla, the electric car company he also helms.
AMC Entertainment Holdings (AMC) Shares Climbed, What Is Driving Attention Now?
AMC Entertainment Holdings (AMC) reported a strong Q2 earnings surprise, with revenue up 14.2% year on year and the stock climbing 48.7% since the report. AMC Entertainment Holdings has leaned into this momentum, with a 30-day share price return of 14.07% and a 90-day move of 36.89%, supported by the recent debt refinancing and the launch of its AMC Movie Trivia Game Show mobile app. The year-to-date share price return of 91.30% contrasts sharply with a 3-year total shareholder return that...
Netflix has stopped talking about plans for video games and podcasts
When Netflix released its third-quarter earnings on Tuesday, the streamer had nothing to say about its games or video podcasts.
SpaceX revenue soars 161% as AI business grows
Elon Musk-led SpaceX issued its second-ever quarterly earnings report on Tuesday.
SpaceX earnings soar past expectations as AI business surges
Elon Musk's company is one of the most powerful companies in the AI economy.
SpaceX Swings to a Profit, Even as A.I. Spending Soars
Elon Musk’s rocket company also said its revenue had more than doubled, driven by its Starlink internet satellite service and artificial intelligence products.
Supermicro Provides First Quarter of Fiscal Year 2027 Preliminary Business Update
SAN JOSE, Calif., October 20, 2026--Super Micro Computer, Inc. (NASDAQ: SMCI) ("Supermicro" or the "Company"), an AI, Enterprise, Storage, and 5G/Edge IT Total Solution Provider, featuring Data Center Building Block Solutions® (DCBBS), today is providing a preliminary business update for the first quarter of fiscal year 2027 (Q1’27), ended September 30, 2026, and schedules earnings call for November 3rd at 5pm EST.
Will PENN Entertainment (PENN) Beat Estimates Again in Its Next Earnings Report?
PENN Entertainment (PENN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
GM’s core profit rises 22% on strength of pickup-truck business
By Kalea Hall Oct 20 (Reuters) - General Motors’ third-quarter results easily beat analyst expectations on the back of resolute shoppers who continue to spring for pricey pickups and SUVs. The company on Tuesday said quarterly earnings before interes...
SpaceX earnings put Elon Musk's Starlink cash cow to the test
Elon Musk is taking a big swing in his bet to turn Starlink into a mobile carrier just in time for earnings.
Caesars Entertainment (CZR) Projected to Release Quarterly Earnings on Tuesday
Caesars Entertainment (NASDAQ:CZR) will be releasing its Q3 2026 earnings after the market closes on Tuesday, October 27. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-10-27-caesars-entertainment-inc-stock/)
Earnings To Watch: Elevance Health (ELV) Reports Q3 Results Tomorrow
Health insurance provider Elevance Health (NYSE:ELV) will be reporting results this Wednesday before market hours. Here’s what investors should know.
ABB says data centre business booming, Q3 figures in line with forecasts
ABB is continuing to see a boom in spending on data centres used to power artificial intelligence, the engineering group said on Tuesday, as it reported its latest earnings.
Revenue And Earnings Growth Could Be A Game Changer For agilon health (AGL)
agilon health has reported strong annual revenue and earnings growth from its model of partnering with primary care physicians to deliver value-based care for Medicare patients through long-term, globally capitated contracts. The combination of accelerating financial performance and the scaling of its value-based primary care network indicates that agilon health is gaining share where payers and physicians seek partners willing to take on population-level risk. We will now look at how agilon...
Nvidia vs. AMD: Which AI Business Has More Room for Margins to Fall?
What separates earnings resilience between NVIDIA Corporation (NASDAQ:NVDA) and Advanced Micro Devices, Inc. (NASDAQ:AMD)? Both sell AI compute, but a dollar of lost margin has a very different effect on their current profits. The stocks rank first and fifth in our 10 Best AI Infrastructure Stocks to Buy for the Long Term, respectively. See which […]
Travelers earnings rise as commercial insurance pricing stabilizes
Travelers reported higher third-quarter earnings Friday as commercial insurance pricing stayed largely stable and investment income rose.
Pat McAfee Net Worth in 2026: ESPN Salary, NFL Earnings and Business Ventures
Pat McAfee has turned a seventh-round punting career with the Indianapolis Colts into a sports media fortune, and his next ESPN contract could double what he al
J.B. Hunt third-quarter earnings rise narrowly, revenue up 20%
J.B. Hunt Transport Services Inc., a Lowell-based transportation services company, posted gains in earnings and revenue in the third quarter of 2026 as freight demand and costs rise. After markets...
Seaport Entertainment Group Announces Third Quarter Earnings Release and Conference Call Dates
NEW YORK, October 15, 2026--Seaport Entertainment Group Inc. (NYSE: SEG) ("Seaport Entertainment Group" or the "Company") today announced it will release its third quarter financial results after the market closes on Wednesday, November 4, 2026. The Company will host a conference call and audio webcast to discuss the results on Thursday, November 5, 2026 at 8:30 AM ET.
Hungry for Scale, Wary of Reimbursement: The Behavioral Health M&A Dilemma
To sell or not to sell, that is the question facing private equity and behavioral health operators today. Timing the market has rarely felt this
Quarterly income up almost 5% for Centennial Bank parent company
Conway-based Home BancShares on Wednesday (Oct. 14) reported third-quarter net income of $129.451 million, up 4.7% compared with the same period in 2025. The per share earnings of 65 cents...
DFW Business Datebook: AT&T, Texas Instruments and airlines report
Fort Worth-based American Airlines and Dallas-based Southwest Airlines will report third-quarter earnings this week in key moments for each carrier.
Melco Resorts And Entertainment (MLCO) Stock May Be A Bargain Following REM Hotel Launch
Melco Resorts & Entertainment has seen its share price under pressure in recent years, which puts a spotlight on a simple question for investors who care about fundamentals. Is the current valuation of Melco justified by the earnings the business is generating today and is expected to earn in the future? Over the past 5 years the stock price has fallen 63.6%, which puts past shareholders' experience and today's earnings based valuation question in sharp contrast. The upcoming REM hotel...
Goldman Sachs CEO Solomon on earnings: We have a big, durable, diverse business
CNBC’s Kate Rooney and David Solomon, Goldman Sachs Chairman and CEO, join 'The Exchange' to discuss earnings going forward, M&A activity, and more.
Netflix reportedly cutting about 1,000 jobs in largest round of layoffs since 2022
Netflix reportedly plans to eliminate 1,000 jobs across several departments in its biggest layoffs since 2022, days before its third-quarter earnings report.
Drake Bell urges followers, ‘Do not become an actor,’ after SAG health insurance denial
The “Drake & Josh” alum did not hit the minimum earnings requirement to secure benefits.
Drake Bell urges followers, ‘Do not become an actor,’ after SAG health insurance denial
Drake Bell did not make the required minimum earnings to secure health benefits with SAG-AFTRA, so he urged people to avoid becoming professional actors.
Uber pay varies, falls below minimum wage in some US cities
A study reveals Uber drivers' earnings differ significantly between US cities, with some making less than minimum wage after expenses.
The Treasury just fined BofA $1.2 billion
A BofA spokesperson said the fine would impact the bank's coming quarterly earnings.
Madison Square Garden Entertainment: Expect Strong Q1 Earnings To Drive A Re-Rating
Madison Square Garden (MSGE) stock remains a Buy: strong earnings, packed concert lineup, and NYC tourism tailwinds. Read here for a detailed analysis.
Optum Health surge helps power UnitedHealth Group results
Optum's earnings from operations leaped 48% to $3.7 billion during the third quarter, UnitedHealth Group reported.
Encompass Health (EHC): Buy, Sell, or Hold Post Q2 Earnings?
Encompass Health has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15.7% to $124.41 per share while the index has gained 13.5%.
Are Investors Undervaluing PENN Entertainment, Inc. (PENN) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Albertsons Beats Second-Quarter Earnings Estimates but Withdraws 2026 Guidance Amid Business Review
Albertsons Companies, Inc. (NYSE:ACI) reported second-quarter fiscal 2026 adjusted earnings above analyst expectations, although declining comparable sales and weaker profitability prompted the US grocery retailer to withdraw its full-year financial outlook.
Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earnings
Bellwether Johnson & Johnson will kick off the third quarter earnings reporting period on Tuesday, with analysts searching for news on business development, launch execution and more.
UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
UnitedHealth Group said it expects 2026 adjusted earnings of at least $20.50 per share, up from a previous outlook of $19.50 to $20.00 per share.
Is Salesforce Still The Business You Bought?
If you hold Salesforce (CRM), you likely bought into a subscription software provider known for steady growth and reliable cash generation. During its fiscal Q2 2027 earnings call in August, management noted that a $25 billion accelerated share repurchase was still under way.
Astrana Health (ASTH) Stock Could Look Fully Priced On New Multi State Partnership
Astrana Health has delivered a strong run in 2026, and with the share price closing at US$37.55, the key issue for you is whether those gains are backed by the company’s earnings power. A year to date return of 48.9% puts Astrana Health’s valuation question front and center, because such a move can quickly change how its earnings are being priced. The recent multi state partnership with Verda Healthcare may support expectations for future revenue and profit streams, which can feed directly...
CVS Health’s Valuation Suggests Opportunity, but Can Earnings Deliver?
CVS Health Corporation (NYSE:CVS) operates across several areas of healthcare, including health insurance, pharmacy benefit management, and retail pharmacy services. Although its diverse range of businesses provides it with access to a variety of revenue sources, increasing medical costs, pressures relating to reimbursement, and ongoing regulatory scrutiny are still affecting its profitability. For investors, the main […]
Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call
Oscar Health will release its third quarter 2026 financial results on Thursday, November 5, 2026.
DHT Holdings, Inc. Business Update
HAMILTON, BERMUDA, October 12, 2026 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update: For the third quarter of 2026, the Company estimates time charter equivalent (“TCE”) earnings for its fleet at $141,300 per day, comprising $167,100 per day for the Company’s VLCCs operating in the spot market and $114,200 per day for the Company’s VLCCs on time charter. These estimated TCE earnings are based on 2,055 revenue days during the quarter, of which
Shares supported as oil retreats; focus turns to US CPI, earnings
By Danilo Masoni and Wayne Cole MILAN/SYDNEY, Oct 12 (Reuters) - European shares and US futures edged higher on Monday after a choppy session in Asia as oil prices retreated,
Share markets choppy in Asia as earnings loom, oil slips
By Wayne Cole SYDNEY, Oct 12 (Reuters) - Stock markets got off to an erratic start on Monday as earnings season looked set to test high tech valuations, while oil
Shares cautious in Asia as earnings loom, oil slips
By Wayne Cole SYDNEY, Oct 12 (Reuters) - Asian share markets got off to a cautious start on Monday as earnings season loomed as a challenge to sky-high tech valuations,
Hinge Health (HNGE) Stock Still Looks Pricey On Earnings Power
Hinge Health has delivered very strong share price gains recently, which puts fresh attention on whether that move lines up with what the business is actually earning. With the stock now trading at US$102.90, the immediate issue for investors is how that price stacks up against its earnings power. The share price is up 125.9% year to date, which raises the question of whether the earnings picture has kept pace with the market's optimism. The business model depends heavily on converting its...
Boone Health earning statements indicate financial trouble despite 2025 profits
For the first half of 2026, the hospital’s earnings were sitting at negative $5.2 million, according board documents.
CVS Health (CVS) Stock Looks Reasonable On Fresh Vaccine Access News
CVS Health, the integrated pharmacy and health services group, has delivered a 35.0% share price gain over the past three years, which puts fresh attention on whether its current US$86.16 price fairly reflects what the business earns today. With the stock giving back some ground in recent weeks, investors are again asking how much of CVS Health's earnings story is already in the quote. The 35.0% return over three years has rewarded patient holders, which raises the question of how much of...
Elevance Health (ELV) Stock May Be Undervalued Despite 2027 Medicare Advantage Plans
Elevance Health has delivered a solid share price run recently, and that move puts a spotlight on a simple question for investors who care about fundamentals. Is the current valuation of the stock properly anchored to the earnings the business is generating today? Over the past year, Elevance Health has returned 19.2%, which puts fresh pressure on the question of whether the earnings profile can carry the current share price. The planned 2027 Medicare Advantage offerings aim to simplify...
Has Elevance Health (ELV) Earned Its Discount After Medicare Updates?
Elevance Health has delivered solid gains over the past year, and fresh product updates in its Medicare business keep the story moving. The open question for anyone looking at the stock now is whether that share price is adequately backed by the company’s earnings power. With a 19.2% return over the past year, Elevance Health has rewarded holders, which puts more focus on whether that move lines up with its earnings profile. The planned 2027 Medicare Advantage offerings aim to provide more...
Data & Business Process Services Stocks Q2 Results: Benchmarking SS&C (NASDAQ:SSNC)
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how data & business process services stocks fared in Q2, starting with SS&C (NASDAQ:SSNC).
J.B. Hunt Q3 earnings, revenue to rise, analysts say
J.B. Hunt Transport Services Inc., a Lowell-based transportation services company, is expected to see earnings and revenue increase in the third quarter compared with the same period in 2025, according...
Is Academy Sports and Outdoors (ASO) Still Cheap On Earnings?
Academy Sports and Outdoors has delivered solid gains for long term shareholders, which puts a spotlight on whether the current share price at US$52.76 is still well supported by its earnings power. With that kind of track record in the rear-view mirror, the key issue now is what those profits are worth today. A 33.9% return over the past 5 years means long term holders have been rewarded. Fresh buyers need to ask whether the present valuation still lines up with the earnings that underpin...
European majors' strong earnings growth expected to have continued in Q3
Major European companies are expected to report substantially higher third-quarter earnings, the latest LSEG I/B/E/S data showed on Thursday, although the year-on-year growth should slightly temper from the previous quarter.
Delta Q3 earnings preview: Premium business expected to blunt high fuel costs; CEO Bastian, Musk battle over in-flight wifi
Delta Air Lines will report third quarter results Friday morning, with investors expecting Delta's premium business to continue to blunt issues like rising fuel costs and capacity cuts.
PepsiCo CEO Ramon Laguarta: We would not split snacks and beverage business
Ramon Laguarta, chairman and CEO at PepsiCo, joins 'Squawk on the Street' to discuss the company’s latest earnings, how consumers are faring amid high inflation, and more.
CVS Health (CVS) Stock May Trade Below Fair Value On Integrated Care Push
CVS Health has delivered a 37.5% share price gain over the past three years, which puts fresh attention on a simple question. Is the current US$87.95 price tag adequately explained by the earnings power investors are paying for today? The 37.5% return over three years means anyone buying now needs to judge whether that past performance has already reflected what the business is earning. Recent developments, from extended distribution agreements with Cardinal Health and McKesson to regulatory...
PepsiCo beats earnings expectations, lowers guidance as it aims to stabilize North America business
PepsiCo stock pops following better than feared results.
Sporticast: Can the Premier League Thrive With Fewer Stars?
On the 593rd Sporticast episode, Lev Akabas, Justin Birnbaum and Jacob Feldman fill in for Scott and Eben to discuss a week’s worth of sports business news. Justin recently published Sportico‘s annual list of the world’s highest-paid soccer players, with Cristiano Ronaldo leading the way with roughly $300 million in earnings. Only one of the …
Samsung Q3 profit jumps nearly nine-fold as AI memory boom lifts chip earnings
Samsung Electronics on Thursday projected a nearly nine-fold jump in third-quarter operating profit from a year earlier, beating analysts' estimates as booming demand for artificial intelligence chips drove strong memory earnings.
Who Won August and September: Original Films or Franchises?
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) I just heard someone say that if you’re reading a pundit or data analyst, and they don’t tell you that they got anything wrong, they’re not a pundit but an “influencer”. I agree with that. You have to tell your audience when you get things wrong, or they won’t (or shouldn’t) trust you as much. Today, we’ve got another edition of “What I Got Right, What I Got Wrong”. In general, I’m patting myself on the back (and patting very hard) about a few things like IP at the box office, LIV golf, horror films, crowdfunding movies, superheroes, and old people going to the theaters. That said, I also made a couple of data mistakes on the streaming bubble popping and HBO’s datecdotes, so I’m not perfect. But first, I need your feedback... Subscribe Follow-Ups: What Should We Call Mid-Budget Movies Which Aren’t Cinematic Enough for Theaters But Are Too Expensive to Make Money on Streaming? After I asked for feedback on what we should call straight-to-streaming films that are too big to pencil out on streaming but not really big enough to resonate in theaters, I got some great suggestions from you all, including... “Moldilocks” from John Aboud “Little Big Indie” from Travis Frick1 “Midflicks” from Jonathan Funke. “Extra-Medium” from Jona Nwuke. (Read the explanation in the footnote.) Between these and Brandon Katz—who suggested “Bermuda Budget Triangle”, “The Platform Gap” and “The Distribution Deadzone”—we’ve got some excellent suggestions. And they’re better than my suggestion, the “Streaming Budget Dead Zone”, so let’s take a poll! The winning entry becomes the new term. Loading... RIGHT: LIV Golf is Fully Bankrupt…Is Anyone Else Next? A few years ago, I was always a bit perplexed at all the articles I’d read praising LIV Golf and their strategy to disrupt the PGA. LIV Golf, a brand new professional golf league, offered PGA stars ten times what they made on the PGA Tour to join their new league. And folks praised this strategy for its initial “success” in that a lot of big names did indeed leave the PGA. Yeah, of course the players came over. LIV Golf paid them so, so, so much more! But LIV Golf hadn’t discovered a way to increase potential revenue. So think about this in basic business terms… They paid much more in costs… …but had no real way to increase revenue. That’s not a strategy! That’s deficit financing. It won’t work unless you bankrupt the competition (and then turn around and pay those same golfers much, much less). It’s not a sustainable strategy and only lasts as long as the company/person/nation backing it decides they’re cool with losing money. For LIV Golf, that meant Middle East oil wealth, in particular Saudi Arabian money. Clearly, the current Iran War has hurt Middle East finances, so they need to trim their more exorbitant spending. And LIV Golf was part of that trimming. This should be a major warning for others. TGL’s parent company, TMRW Sports, just got a $1 billion valuation, despite TGL’s (the indoor golf league) horrible TV viewership of less than half a million viewers per match. Unrivaled, the women’s basketball league, just secured a $650 valuation, despite its horrible TV viewership and a new rival (Project B) entering the scene next year. To relate this to streaming, Hollywood should ask which streamers may have wealthy patrons funding their losses. (Let’s be clear: Google, Amazon and Apple.) Could those patrons lose their appetite? For Amazon, probably not. But Apple has a new boss, so maybe! WRONG: My Analysis of the Streaming Bubble Was Missing a Week I’m going to be congratulating myself a lot today, but I make mistakes too, like this data goof. When I last compiled the data on the decline in TV shows, I was missing one week at the end of June. If you look at the first image, you can see that one week was mislabelled as “July”. Mainly, this image got updated to show a 27% decline, not 29%: This change doesn’t really impact the overall analysis, but it is two percent better. By the way, through the third quarter, the decline increased and it’s now a 30% decrease since 2022. (I’ll write/visualize this in an upcoming article.) But I want you to trust me and my data. Especially these days, when many people are using LLMs that I know are inserting faulty data into their charts, I want to keep earning my audience’s faith. So that’s the accurate data. RIGHT: IP Remains Very, Very Popular In July, I wrote a giant (and I mean giant) article on Backrooms, Obsession, and the box office, going over what we know, what we don’t know about what works in theaters, looking at YouTubers, IP, the horror genre, comic book movies, and a whole lot more. The month of August really tested a lot of my theses and, being honest, mostly supported my arguments. Let’s start with IP. Looking at 8-Aug (the weekend after Spider-Man: Brand New Day came out) to 18-Sep (the weekend that Resident Evil came out, which I think provides a nice bookend to this time period), there were seven films based on pre-existing IP: Resident Evil (2026) ($126 million) Practical Magic 2 ($65 million) _Insidious: Out of the Furthe_r ($65 million) Coyote Vs. Acme ($59 million) Paw Patrol: The Dino Movie ($53 million) Tony ($15 million) Super Troopers 3 ($7 million) Compare those to the notable original films from the past month—I actually could have included more movies, but here are just thirteen, bringing us to an even twenty films—including.... The End of Oak Street ($54 million) Buddy ($26 million) Mutiny ($15 million) By Any Means ($15 million) The Dog Stars ($14 million) Runner ($14 million) One Night Only ($11 million) Hope ($8 million) Spa Weekend ($7 million) The Uprising ($6 million) Teenage Sex and Death at Camp Miasma ($6 million) Onslaught ($3 million) Eli Roth’s Ice Cream Man ($2.8 million) Here’s that in chart form: Five of the top six films in this time period were all based on IP. I made a big chart of films that grossed over $200 million at the box office before Spider-Man: Brand New Day and The Odyssey hit theaters. Let’s update that chart! By the way, if you want to see how I categorized each film—so another bar chart—here it is: I know that many of my fellow critics/pundits/analysts dislike films based on IP and how Hollywood is making so many of them. And I’m sympathetic to this point of view. As I’ve written many, many times before, you need a balance between existing franchises, new IP, and original films. And Hollywood clearly needs to make more films like Resident Evil (a well-made film from a visionary director) and fewer Practical Magic 2’s (which didn’t get critical or customer buzz). But at some point, critics and pundits need to contend with what audiences are telling them: Movie-goers aren’t showing up to original films. Audiences are speaking with their dollars, telling you they want more IP and franchises. You can try to convince studio heads to make fewer IP-based films and franchises, but the data and numbers aren’t there. Instead, critics need to work harder to convince audiences to show up for original films. Aim your ire/concern at the average person, not studio heads.2 Because they’re just making the films that audiences are telling them to make. WRONG: Original Horror Films Didn’t Break Out I’ll be honest, even though I wrote an article casting some skepticism on the horror genre in July, if you asked me to make a prediction, I would have predicted that, in August, a new, original horror film would have blown up. No, seriously, I just assumed that Obsession and Backrooms presaged a change in audience behavior. But none of the buzzy new original horror films from August—Teenage Sex and Death at Camp Miasma, Onslaught (not an action film in spite of the ads), The End of Oak Street, Eli Roth’s Ice Cream Man, or _Buddy—_broke out. To be clear, exactly one of those films (Buddy) had good “ROI”, but again—I try to be specific in my language—none were “popular” in any broad sense of the word. None of them will be “saving” movies theaters like Backrooms or _Obsession_helped save the summer. The new Insidious film and Resident Evil, both based on IP, were far and away the biggest horror films since July. (We’ll see if this changes in October/Halloween season.) RIGHT: Stay Skeptical about Crowdfunding... I’ve long been skeptical about crowd-investing platforms as one of Hollywood’s saviors, mainly because there’s so much hype/buzz. People need to stay more skeptical about more things, explaining both the potential upside but also the downsides. In particular, the media often hypes crowdfunding at the start and never checks in on the actual results after they’ve come in later. And August gave us our first update! _Ice Cream Man—_directed by Eli Roth—grossed $6 million off of a $5.5 million budget. This is a production of The Horror Section, which was one of the first “crowd investing” studios with 2,400 investors, which means that 2,400 investors probably lost money. They certainly aren’t getting as great of returns as if they had just invested their dollars in the stock market. Hopefully Stiletto (Tagline: “Someone’s Going to Make it Rain Blood!”) does better next month. WRONG: Another Data Goof Here’s another data error. When the first episode of House of the Dragon came out, HBO put out that it had 21.5 million viewers in the first three days, and I read that to mean in the US…but no, it was global. So my US-only datecdotes charts shouldn’t have included it. We never got US-only numbers for the first episode, but for the final episode, HBO put out that it had 11 million US viewers. (And that global dropped to 21 million viewers.) Here’s the updated chart (which I’ve since used in the Streaming Ratings Report): Still, this show is absolutely huge. RIGHT: Superhero Films Remain Very, Very Popular After Supergirl flopped, I read a few takes that “comic book movies are going the way of the Western”. Post-Spider-Man: Brand New Day, that take didn’t age well. To be fair, I have a very nuanced take on the superhero genre right now; it’s down right now, for a lot of reasons. But it’s not “dead”. Maybe _Spider-_Man is just a really popular character? I saw that take, and it’s a fair counter-argument. (But pundits arguing that superhero movies were dead should have mentioned this $1.5 billion counter-argument…) But is it just Spider-Man? The next Avengers film already has $50 million in pre-sales (and I was skeptical that that film would do well) and the Avengers: End Game re-release topped the box office two weekends ago (over three original films). And I wouldn’t bet against Batman or Superman. So maybe it’s just Spider-Man, Batman, Superman and the Avengers. Oh, and Deadpool, of course. And Black Panther. And Wolverine. And probably the X-Men. Plus a well-made Wonder Woman or the Hulk film could break out. But that’s it! It’s just those ten characters/teams. Oh, what’s that? Lanterns is also doing well on HBO? (See previous section…) To be fair, I’m actually pretty sympathetic to the argument that more popular characters—like Spider-Man and Batman—anchor more popular films. In fact, I made that exact argument three years ago when I first wrote about the “Marvel-cession”. In many ways, you can blame The Guardians of the Galaxy for fooling Marvel Studios (and the rest of us) into believing that any character could pop. It turns out, the list of iconic characters is probably smaller than most people think. But it’s probably too early to say that superhero films and comic book movies are dead unless “death” means a slight decline over a longtime. RIGHT: Who Killed Theaters? Old People I get frustrated whenever I see headlines or analysis about how young people are “returning” to theaters. As I’ve detailed(for years), young people have always powered the US box office, despite narratives about “kids these days” and their “phones”. Really, what’s changed post-2020/pandemic is that old people aren’t going to the movies nearly as much. This summer, I saw a movie (from an older director) in a theater near a retirement community, and multiple older people at the theater were talking about how this was their first time seeing a movie in years. I dislike personal anecdotes, so YouGov can fill in the data, best summarized by this headline: “Who killed movie theaters? Not the youths”. According to them, 64% of people aged 18-29 have seen a movie in the last year, but only 30% of 65-and-older. 20% of 18-29 have seen a movie in theaters in the last week and 42% in the last month. Here’s the polling data: Most concerning? Many Americans (17%) think theaters are a worse or much worse experience than watching films at home. Slight WRONG: Hadestown Opens Big A live theater capture of the Broadway musical, Hadestown, made $20 million at the US box office, which begs the question: was I wrong to be skeptical about musicals a few years ago? Yes and no. On the one hand, $20 million is a far cry from being “popular”, so yeah, the genre isn’t that popular overall and Hadestown is one of the more popular musicals from recent years (i.e. the “Taylor Swift Data Fallacy” in action). On the other, I doubt filming this cost all that much, and I don’t think that they spent much on marketing, so this is a good source of ancillary revenue. Smaller Updates WRONG: As I mentioned in a Streaming Ratings Report, I underestimated the budget for Enola Holmes 3. It probably cost more like $50 million, if not more. But... I’m not sure that it really matters? At sub-10 million hours, prices have to come down to make this work. WRONG: Netflix is giving Ink a 27-day in theaters! To quote the kids/YouTubers these days, let’s go! Now I might actually have a chance to see Danny Boyle’s latest in theaters. I’d complained about this in a “Coming Soon” section, but I was heartened to read that Netflix is giving multiple films longer theatrical windows this year. RIGHT: Netflix is sending 4-5 films per year to theaters. Netflix is slowly but surely sending more and more films to theaters, as I cautiously predicted earlier this year. For now, it’s just three big films and a number of awards contenders, but still, this is great news. And they’ll be releasing box office grosses! Just this week, Ted Sarandos confirmed that KPop Demon Hunters 2 will come to theaters (and my guess is it performs in the box office top ten at a minimum). WRONG: Angel has 3 million subscribers! How do I know this? Well, they told Deadline, who reported it. I marked this as “wrong”, since they’ve doubled their subscribers in one year but, you know, they don’t really have a hit film to speak of and they’re still losing money. WRONG: Furious was only renewed for one more season. I accidentally wrote “two more seasons” in my latest “Renewals, Cancellations, Un-Orders and Removals Update”. RIGHT: House of David is ending with its third season. In July, Prime Video renewed House of David for a third season, as I just wrote in my latest “Renewals and Cancellations” report. Well, now it’s ending after that third season. Why? As I’ve been writing, its viewership wasn’t great. I got feedback that this show didn’t cost very much, but it cost enough that its limited viewership didn’t save it. WRONG: Adults was a Hulu original! So I missed Adults when it first came out last year; I saw that it aired on FX and just assumed that it was a linear-first program. Turns out, it aired three episodes on FX, but binge-released the rest of its episodes the next day on Hulu. Huh. So I should have covered it last year! But I just wrote about it. 1 “When I was a kid in the 90s, if you wore a t-shirt to school that wasn’t too big and also wasn’t too small, but somehow didn’t quite fit, we’d say you were wearing an “extra-medium” shirt.” 2 As always, a huge exception is Disney, which barely makes anything original anymore.
Accel Entertainment Announces Third Quarter 2026 Earnings Conference Call and Webcast
Accel Entertainment will announce third-quarter financial results on November 3, 2026, followed by a conference call and webcast.Quiver AI SummaryAccel Entertainment, Inc. announced that it will release its financial and operating results for the third quarter ending September 30, 2026, on November 3, 2026, after market close. The Company will hold a conference call and webcast at 4:30 PM ET to discuss the results, featuring CEO Mark Phelan and o
Why Markets Are Buoyant
Energy and technology companies’ earnings are expected to keep driving up stock indexes. But what’s driving up their profits are weighing on the economy.
Why Costco and Walmart stocks are falling despite strong sales, earnings
Costco and Walmart are gaining shoppers, but their premium valuations leave little room for anything short of near-perfect growth.
Cargill’s earnings slump 52% with high cattle costs, cocoa loss
Cargill Inc.’s fiscal first-quarter earnings fell by more than half as the largest private company in the U.S. was pressured by higher costs for cattle and cocoa despite also benefiting
Nasdaq notches record high close as investors focus on earnings
Nasdaq reached a record high close driven by Nvidia and Microsoft gains amid investor focus on earnings and lower oil prices.
How a controversial camera system is monitoring mental health patients
The Lampard Inquiry started back in September 2024 and I remember going to the first hearing in Chelmsford. Subscribe The bereaved families made placards of their loved ones, they stood outside in silence and then laid flowers to mark the moment. Now, two years on, in a process meant to last another two years, there’s been a development. Last week, we were told the chair, Baroness Lampard, pictured below, could be looking at making interim recommendations. Throughout the process, she has remarked that although this inquiry is looking at almost 2,000 people who were under the care of Essex mental health services from 2000-2023 when they died, the findings could have national implications for other trusts. ‘Records 24 hours a day in patient’s bedroom’ So why has this happened? One system that the inquiry is going to take a closer look at is a controversial monitoring system called Oxevision. It monitors some vital signs of patients remotely by using a camera placed in a room. It’s used by 40% of NHS mental health trusts. But campaigners, particularly the group Stop Oxevision, have asked for this technology to be removed from mental health wards as soon as possible. I spoke to a member, Hat Porter, today and they described to me what they thought this technology did and explained their concerns: “It records 24 hours a day and it’s located in a patient’s bedroom, which is obviously somewhere you’d usually expect to be a private place. “Our concerns are that the use of the technology has been has been kind of implemented as a substitute for proper in-person support, that it’s kind of over relied on and that there’s a lot of misunderstandings and that the presence of a camera, which has often been used without people’s consent, sometimes without even their knowledge, that that has a really big impact on privacy, dignity and human rights.” ‘Not sufficient’ I put it to them that the company behind Oxevision would dispute their claims about consent and in videos I’ve seen online from NHS trusts, they make it clear that the technology is complementary to trained staff and not a replacement. [ ](https://channel4news.substack.com/p/the-nottingham-inquiry-what-lessons) [ How the Nottingham inquiry shines a spotlight on other key mental health care failings ](https://channel4news.substack.com/p/the-nottingham-inquiry-what-lessons) Victoria Macdonald · Feb 12 [ Read full story ](https://channel4news.substack.com/p/the-nottingham-inquiry-what-lessons) A team of lawyers has been working on the inquiry and with bereaved family members who have concerns about this technology. I spoke to solicitor Priya Singh, from Hodge Jones & Allen, who made the point that questions usually asked by nurses would be missing from using devices like this. “It’s not sufficient to say, oh, the patient is moving around. Somebody must go in and say, are you okay? Are you distressed? Do you want help? Is there anything I can do? Share Channel 4 News “How are you spending your time? So I think a lot of our families cannot see the function of it when ultimately the patient should only really be observed when they’ve been prescribed to be observed, they can be observed more, but that more should really be happening face to face.” The Chair will hear evidence over the next two weeks and then a decision made after that, which could have national impact if she does decide this technology should be investigated or even removed. The Department of Health and Social Care said: “The Government is committed to ensuring that lessons are learned from the Lampard Inquiry to improve patient safety. “We are confident that the Inquiry will play an important role in identifying wider learnings for the health system following the tragic events in Essex and will contribute to improvements in patient safety.” We approached LIO Health, which runs Oxevision, for comment. Subscribe Share Channel 4 News Leave a comment
Cal-Maine cracks open new growth opportunities
Earnings plunge amid low egg prices and investments in prepared foods.
I'm a classic old school Conservative, says Kemi Badenoch
The Conservative leader tells the BBC the earnings threshold for government support stops people "working harder".
Caesars Entertainment, Inc. to Release 2026 Third Quarter Results on October 27, 2026
LAS VEGAS & RENO, Nev., October 02, 2026--Caesars Entertainment, Inc. (NASDAQ: CZR) ("Caesars", "the Company") will release its financial results for the third quarter after the market closes on Tuesday, October 27, 2026. Considering the Company’s pending merger with Fertitta Entertainment announced on May 28, 2026, Caesars will not host an earnings call. Upon completion of the proposed merger agreement, Caesars’ common stock will no longer be listed on NASDAQ, and the Company will become a priv
Accenture finishes year with $85 billion of new business, says CEO Julie Sweet
Accenture CEO Julie Sweet joins 'Squawk on the Street' to discuss on company earnings, the adoption of AI, and more.
September Monthly Review: Health MCP Guy?
For all the time I spend talking about APIs and data exchange, this newsletter has had embarrassingly little interoperability of its own. It’s old-school SaaS, baby - UI or bust. Not all of that is my fault! Substack, for all its popularity, is (as mentioned before) really frustrating as my system of record. The primary user it optimizes towards is the reader, whose attention feeds the app, the Notes feed, and the recommendation network that Substack is actually selling. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe They’re falling into the same trap that Medium once sprinted into, albeit at a much more glacial speed. Younger generations may not remember (or never knew) it, but Medium once lured publications like The Ringer and Signal v. Noise onto its platform, only to lose them as it rebuilt itself around a paywall and an algorithmic feed. Substack’s original pitch circa 2020 was the antidote (you own your list), but every new feed feature chips away at it. I get it: writers are generic supply in the eyes of the Substack product team. Generic supply follows demand, so the consistent pressure on the PMs is to generate demand, which leads to every product cycle going toward discovery (Notes, recommendations, the app, live video). The end result lackluster author tools (laggy and broken analytics are truly crippling) all despite the premium price point. The archive is where it crosses from authorial gripes to actual reader impact, though. Across Substack and LinkedIn, I’ve published 1,218 posts and nearly 900,000 words since 2018. Substack’s native search can see only the 464 posts that live on Substack, and even there it’s woefully inadequate at surfacing relevant content (even for the guy who wrote it)! Readers have the same problem, writ large. Ask the Archive Fixing search (for both my readers and my own use) turned out to be extremely non-trivial, unfortunately: There’s no public API for readers to access content RSS exists for new content notification, but it only carries the 20 most recent posts and cuts paid ones off at the preview The only Substack MCP is an admin tool for analytics The export exists for authors, but it’s painfully awkward and slow. So I built something to work around that: the Health API Guy MCP. It’s a private MCP server holding the full text of everything I’ve written across Substack and LinkedIn. Add it to Claude or ChatGPT as a connector and you can ask things like: It pairs keyword search (for acronyms and case names, of which we have many) with semantic search. Every post is also labeled by topic, form, and court case, so you can pull a lawsuit’s (or multiple cases’) entire docket across Substack and LinkedIn in one query: Hail, Healthapiguyhydra This is also a bit of me eating my own cooking. I’ve spent the year arguing that headless healthcare is arriving and that developers want primitives over abstractions. Last week in Hail, Benihydra, I watched Salesforce plug its platform into Claude and bet that the records underneath outlive whatever interface sits on top: Salesforce must believe that the Hydra’s immortal head is the records, permissions, and business logic (in that they will survive whatever happens to the interface). It felt a bit hypocritical to keep my own archive behind a Substack search bar. The archive is the body. Substack is one head, and now whatever tool you might use is another. Will the EHRs follow my lead? Probably not imminently, but one can hope! Why Founding Members Only The MCP is available to Founding Member subscribers. A few reasons: It costs money and time to run. Hosting, the database, Clerk usage and AI compute for search and labeling are significant operational costs (that increase with usage). Substack gives me no way to automate access. There’s no API to check whether someone is a paid subscriber, so every user is manual operations for now. It’s a beta. We’ll need to improve things and parts will break. I’d rather they break for a small group of dedicated readers who will tell me about it. The Founding tier deserved a real benefit. Until now it was mostly a generous tip. Now it comes with something. If you’re already a Founding Member, reply to this email with the address you’d like provisioned. If you’re not and want in, upgrade here. Larger teams (such as companies) can get access too: group subscriptions at the Founding tier come with the group discount. The admin for the subscription can reply with the list of addresses to provision. Get 20% off a group subscription Pricing Founding membership is now a flat $200 a year, replacing the old suggested $150 that readers could adjust. Existing Founding Members will have access grandfathered in at their previous rate. Month in Review Articles Published Make Networks Dumb Again (Sep 11): AI is making old analog networks cheaper to use and flooding them with machine traffic in the process. A plea for agent-native rails with the intelligence at the endpoints, and for Washington to drag them to ubiquity. Interoperability, Unbuttoned (Sep 29): Interoperability is a series of workflows in a trenchcoat, and this post finally takes the trenchcoat off. A color-coded map shows which provider workflows went digital, which are fragmented, and which still run on fax. Video Content Antitrust’s System of Record Problem (Sep 3): The FTC’s investigation into Epic prompted a ninety-minute webinar, now posted with chapters and a smoothed transcript. We get into why market definition, missing B2B share data, and the SSNIP test leave antitrust poorly suited to systems of record, plus why information blocking may be doing more than any pending lawsuit. The Information Exchange: Cerner Milking Edition (Sep 18): This was so fucking fun. Ryan Tucker, Ryan Brickner, Brad Thorson, and I try an Around the Horn format, complete with points, penalties, and a mute button. We debate whether Oracle Health is dead, who would actually buy Cerner (IBM enters the chat), p(Doom), and why the front desk still hands you a clipboard. Regulatory Ask Not What Your Network Can Do (Sep 23): CDC’s RFI on public health data intermediaries lists use cases already served, unevenly, by eCR, lab reporting, IZ Gateway, and syndromic surveillance. The real opportunity sits in one question about AI: a network that can handle the next emergency without another interface project. Court cases Particle v. Epic: The Naughty Schoolteacher (Sep 4): After a summer-long vigil, the answer on Epic’s early summary judgment bid is two paragraphs and a remedial assignment. Particle advances to the next grade, and market definition gets another year of discovery. The Epic Discovery Files (Sep 8): Texas’s motions to compel arrive with a 251-page appendix of requests, objections, and meet-and-confer letters with Cravath. Inside: Epic using generative AI for document review, denied interoperability requests in scope, and Noerr-Pennington raised against lobbying discovery. Epic v. Health Gorilla: “Working as Designed” (Sep 9): Epic wants nothing to do with the data breach MDL, and explaining why puts fresh discovery on the public docket. The spiciest allegation: Health Gorilla told GuardDog to scrub its law firm business from its website instead of cutting off access. Veeva v. Epic: Legal Bypass Surgery (Sep 15): Veeva asks the Wisconsin Supreme Court to skip the Court of Appeals, while law professors and three policy groups line up as amici. Meanwhile, Epic’s lawyers apologize for another round of citation errors, including a quote that never existed. Texas v. Epic: Behind the Black Bars (Sep 17): The court portal served up Epic’s unredacted filings, revealing a $5 million document review budget and the AI workflow behind it. Also inside: the 200-plus company names Texas wants searched, and one very expensive Zoom invitation. OpenEvidence v. Doximity: Consequences Will Follow (Sep 25): OpenEvidence tells the court it will not comply with a discovery order, and its own lawyers at Quinn Emanuel say they won’t defend the choice. Add years of Slack reported unrecoverable, and Rule 37 sanctions come into view. Health Tech Keeps Choosing Violence (Sep 28): Doximity moves to end OpenEvidence’s case, Epic asks Texas to show its work, and a sleepy Audacious Inquiry patent fight sprouts antitrust and information blocking counterclaims. The main event is a long-sealed Cognizant v. Infosys ruling that hints where system of record antitrust claims can survive. EHRs One Verb for Oracle Health (Sep 14): Oracle’s earnings call quantifies every data center to the decimal point, while Oracle Health gets a single verb: “accelerate.” Panning the few healthcare mentions turns up an agentic care management system, a research-to-care ledger play, and the question of whether healthcare gets Larry’s patience. Epic’s Forretress Under Siege (Sep 30): Judy Faulkner tells a panel Epic paused hundreds of projects to harden its software and calls it a “shame,” while a spokesperson insists the roadmap hasn’t changed. Project Glasswing, a Pokémon-branded QAN sprint, and a trove of Jodel grievances reconcile the two Epics and preview the Jevons paradox coming for all software. Industry Analysis Scanning for a Network (Sep 1): Scan.com raises $220M to build the imaging network labs never got, speedrunning Zocdoc’s consumer-to-B2B pivot. Its wedge to network density may be the most American one available: personal injury litigation. The Front Desk Wants the Damn Whole Building (Sep 16): Hello Patient buys Converse Health, pushing its AI front desk into referrals, chart work, and prior auth. The copilot categories keep blurring, and your distribution partner is still your final boss. Cross-industry Comparisons A Different Patchwork Quilt (Sep 10): Healthcare loves to envy open banking, but the US version has no mandate, a toll booth at Chase, and data quality problems of its own. The grass isn’t greener; it’s another American patchwork quilt, and perhaps a worse one. Hail, Benihydra (Sep 21): Salesforce brings its platform into Claude, Slack, and its own agent, inviting the interfaces that might replace it. Cut off one head and more grow back, so long as the records underneath stay put. Living on A Trade Secret Prayer (Sep 22): Six credit unions are suing Fiserv, the Epic of core banking, by claiming their own member records as trade secrets. Banking has no Cures Act, so its lawyers reach for legal alchemy that healthcare has already tried. Other News None this month External Media Nabla Accelerate NYC: I kicked off fall conference season at Nabla’s Accelerate event in New York, where Delphine Groll opened by asking the room to picture the company it wants to become and the one it doesn’t. I liked her framework of bureaucracy, fear, and ego as the blockers. I also love vendor conferences/events in general - different vibe than industry biggies. Healthcare 101 with Nikhil Krishnan: I briefly guest lectured Out-Of-Pocket’s Healthcare 101 class. Appreciated Nikhil’s takeaways cover whether AI doctors can query HIEs, why healthcare’s data-liberation rules beat most industries’, and the hi-res graphic is in the comments. HCN: Epic Probed by the FTC: I joined the HCN guys to talk through the FTC’s investigation into Epic. Cedric’s new hairdo was an unexpected plot twist. The episode also covers MFN drug pricing, healthcare M&A and Eli Lilly’s acquisition streak. Fall Conferences: At eHealth Exchange’s Annual Meeting in Austin on Oct 27, I’ll moderate a panel on the tensions between AI, HIEs, and timely patient access with Jean Ross (Primary Record), Therasa Bell (Kno2), Byron Crowe (Doctronic), and Michael Marchant (Freenome). Here’s the rest of my schedule if you want to meet up: CommonWell (Redwood Shores, CA): Oct 13-14 Will be participating in a fun Jeopardy event Open@Epic (Madison, WI): Oct 20-23 Will be enjoying Verona, Willy Street, and other local adventures eHealth Exchange and Sequoia Project (Austin, TX): Oct 27-29 Yeehaw HLTH (Vegas): Nov 15-18 Groundhog Day, Venetian Edition RSNA (Chicago): Nov 30-Dec 2 See me at “Governing AI in Breast Imaging: What Health Systems Are Actually Doing” Digital Health Counsel 2026 AI Summit (Seattle): December 2-3 Will likely be speaking to a bunch of lawyers about information blocking Posts I Liked ChatGPT’s Epic integration: game changer or nothing burger?: Joshua Liu, MD offers five thoughts on OpenAI’s Epic launch, starting from the point that it rides the same open APIs available to anyone. He argues read-only access leaves ordering to Art and the ambient startups, and asks why HCA is piloting it alongside Commure. He’s sorta a must-follow at this point - consistently excellent, thought-provoking takes. Epic, Lilly, and the Discovery pass: Seth Chaney reads Epic’s first major Discovery deal (with Eli Lilly), as well as its revised developer terms on commercial displays, as the pipe finally opening between EHRs and pharma. Life sciences and health continue to collide. Scott Rossignol on EHR payer platforms and ePA fees: Scott argues the top ambulatory EHR vendors are turning the prior auth mandate into a per-member-per-year toll on payers, for an API whose operating cost has nothing to do with covered lives. His fix is two lines of regulatory text: put the CRD/DTR/PAS certification criteria in the Base EHR definition, and bring payer-facing ePA connectivity under § 170.404’s cost-based fee rules. It’s a good solution. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
What You Can Learn From WEBTOON Entertainment's 39% Drop
WEBTOON Entertainment’s Q1 2026 report looked mixed on the surface, with revenue slightly weaker than expected but earnings per share comfortably ahead of forecasts. Investors who held WEBTOON Entertainment over the past year are down 39.3%, including dividends. If you had invested just after analysts set out sharply different fair values and earnings paths in late 2025, how should you now interpret that decline in light of WEBTOON’s push into Disney-backed content, AI tools, and a growing IP...
U.S. Small Business Employment Rate Remains Steady in September
Positive weekly earnings and hours worked growth trends continueROCHESTER, N.Y., Sept. 29, 2026 (GLOBE NEWSWIRE) -- According to the Paychex Small Business Employment Watch, which reports on employment levels in U.S. small businesses with fewer than 50 employees, the pace of job growth increased 0.02 percentage points to 99.15 in September. The jobs index remained broadly in line with the 2026 year-to-date average of 99.19. Hourly earnings growth remained below three percent in September (2.78%)
Q2 Rundown: PENN Entertainment (NASDAQ:PENN) Vs Other Consumer Discretionary
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer discretionary - casino operator industry, including PENN Entertainment (NASDAQ:PENN) and its peers.
Earnings matter more than politics for S&P 500 gains, BofA says
Corporate profits drive S&P 500 returns more than politics, says BofA.
Oscar Health (OSCR) Shares Moved, What Is Catching Investors' Attention?
Why Oscar Health’s latest product push matters now Fresh commentary around Oscar Health (OSCR) centers on management’s push for higher earnings per share through tighter medical loss ratios, new offerings such as the Lucy Healthcare Marketplace, and wider use of AI tools. At a share price of $29.60, Oscar Health has pulled back over the past week with a 7 day share price return of down 5.4% and a 30 day share price return of down 2.9%. However, the 90 day share price return of 3.8% and year...
Shift4 Payments (FOUR): A Stock Priced for Trouble, a Business Still Compounding Underneath
Back in August, Shift4 Payments, Inc. (NYSE:FOUR) lowered its full-year outlook, cutting expected gross revenue less network fees to $2.48 billion – $2.53 billion from $2.5 billion – $2.6 billion and adjusted earnings per share to $5.15 – $5.35 from $5.50 – $5.70, citing roughly $25 million from Middle East travel disruption and $20 million […]
Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path
Oscar Health has been on a powerful run in recent years, yet the real question for you today is whether the current share price lines up with what its earnings story can reasonably support. The stock has also seen shorter term pullbacks, which makes the earnings backdrop even more important for anyone trying to judge what they are actually paying for. Over the past 3 years the stock has delivered a very large gain of about 4.3x, which puts a lot of weight on whether the underlying earnings...
Flutter Entertainment (FLUT) Could Be 40% Undervalued On Revenue Beat And EPS Miss
Flutter Entertainment (FLUT) just delivered a mixed earnings update that drew a sharp response from the market, with revenue ahead of analyst expectations but earnings per share falling well short of forecasts. That miss on profitability lands on top of a weak stretch for Flutter Entertainment, with the share price down 18.23% over the past 30 days and falling 61.87% year to date. The 1-year total shareholder return has declined 70.29%, suggesting momentum has been fading as investors...
Oscar Health (OSCR) Stock May Be Undervalued Following Its AI Marketplace Launch
Oscar Health has delivered very strong long term gains for shareholders, yet the recent pullback raises a simple question for anyone looking at the stock today: is the current price still in line with what its earnings can support? Over the past 3 years, Oscar Health has produced a very large share price return, which puts extra focus on whether its earnings can justify that kind of move. Management is talking about higher future earnings per share and better medical loss ratios, which can...
David Beckham Earnings Boom Amid FIFA World Cup
The soccer star and Inter Miami owner saw revenue and profits at his brand business soar even ahead of the 2026 FIFA World Cup.
Costco clinches $184M in tariff refunds, with more expected
Costco confirmed it received $184 million in tariff refunds, with more on the way, according to its latest earnings call. On Thursday, the big-box retailer said the money was reinvested
Cardinal Health (CAH) Stock Looks About Right At Today’s Price
Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a strong multi year run, investors are increasingly focused on what its earnings actually justify. Cardinal Health has returned about 378.2% over the past 5 years, which puts real pressure on the current valuation story to be supported by the earnings profile. The...